InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Browse the detailed record of transactions filed by Heyman Richard A., Director. Insider active across 3 companies, notably Enliven Therapeutics, Inc.. In total, 16 filings have been recorded. Total volume traded: €333k. The latest transaction was disclosed on 8 January 2026 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations16 total
US$34,6841,620 shares@ US$21.41100.0% of flow
Common Stock
SEC:0001584759-26-000004·
€34,6841,620 shares@ €21.410.0014% mcap50.0% of flow
Common Stock
SEC:0001584759-26-000004:0·
€14,982706 shares@ €21.22080.0018% mcap11.4% of flow
Common Stock
SEC:0001209191-21-056461·
€14,982706 shares@ €21.22080.0018% mcap5.7% of flow
Common Stock
SEC:0001209191-21-056461:0·
€10,167479 shares@ €21.2250.0012% mcap7.7% of flow
Common Stock
SEC:0001209191-21-055871·
€10,167479 shares@ €21.2250.0012% mcap3.9% of flow
Common Stock
SEC:0001209191-21-055871:0·
€23,0271,086 shares@ €21.20350.0027% mcap17.4% of flow
Common Stock
SEC:0001209191-21-055295·
€23,0271,086 shares@ €21.20350.0027% mcap8.7% of flow
Common Stock
SEC:0001209191-21-055295:0·
€4,7081,950 shares@ €2.41450.0068% mcap100.0% of flow
Common Stock
SEC:0001209191-21-037144·
€4,7081,950 shares@ €2.41450.0068% mcap50.0% of flow
Common Stock
SEC:0001209191-21-037144:0·
€14,362700 shares@ €20.51710.0017% mcap10.9% of flow
Common Stock
SEC:0001209191-21-035525·
€14,362700 shares@ €20.51710.0017% mcap5.4% of flow
Common Stock
SEC:0001209191-21-035525:0·
€67,3853,215 shares@ €20.95940.0080% mcap51.1% of flow
Common Stock
SEC:0001209191-21-033817·
€67,3853,215 shares@ €20.95940.0080% mcap25.5% of flow
Common Stock
SEC:0001209191-21-033817:0·
€2,068100 shares@ €20.6760.0002% mcap1.6% of flow
Common Stock
SEC:0001209191-21-032510·
€2,068100 shares@ €20.6760.0002% mcap0.8% of flow
Common Stock
SEC:0001209191-21-032510:0·
16 of 16 declarations
About Heyman Richard A.
Richard A. Heyman is a director at Enliven Therapeutics, Inc.
